Teva Pharmaceutical Industries Comprehensive Income 2010-2024 | TEVA

Teva Pharmaceutical Industries comprehensive income for the quarter ending June 30, 2024 was $-2.881B, a 7.62% increase year-over-year.

  • Teva Pharmaceutical Industries comprehensive income for 2023 was $-2.697B, a 4.97% decline from 2022.
  • Teva Pharmaceutical Industries comprehensive income for 2022 was $-2.838B, a 5.78% increase from 2021.
  • Teva Pharmaceutical Industries comprehensive income for 2021 was $-2.683B, a 11.84% increase from 2020.

Teva Pharmaceutical Industries Comprehensive Income 2010-2024 | TEVA

  • Teva Pharmaceutical Industries comprehensive income for 2023 was $-2.697B, a 4.97% decline from 2022.
  • Teva Pharmaceutical Industries comprehensive income for 2022 was $-2.838B, a 5.78% increase from 2021.
  • Teva Pharmaceutical Industries comprehensive income for 2021 was $-2.683B, a 11.84% increase from 2020.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$13.1B
BridgeBio Pharma (BBIO)$5B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$1.8B
Taysha Gene Therapies (TSHA)$449M
Personalis (PSNL)$315M
Assembly Biosciences (ASMB)$117M
Acasti Pharma (ACST)$28M
Sol-Gel Technologies (SLGL)$20M
Evoke Pharma (EVOK)$4M
Teligent (TLGT)$0M